Gene Fears by Doping Body
By Edinburgh Evening News,
Edinburgh Evening News
| 06. 12. 2008
THE World Anti-Doping Agency has called for increased awareness of the dangers of gene doping.
Defined by WADA as "the non-therapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to improve athletic performance", it is thought to be the next big performance-enhancing threat in world sport.
After a symposium on the subject in St Petersburg, WADA vice president Professor Arne Ljungqvist said the organisation had an important role to play in informing athletes of the problems it could cause.
He said: "Most experts do not think that gene transfer is being misused by athletes yet, but we know that there is a growing level of interest in the sports world in the potential for gene doping, and that scientists working on potential genetic cures for muscle diseases or blood disorders are being approached by sports figures to inquire about the use of genes to enhance performance in sport.
"We need to make sure that athletes know the dangers associated with these technologies, and, for those who may choose to ignore them and...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...